Picture of PACSCo logo

PACS — PACSCo News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro Cap

Interim Results

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241209:nRSI2347Pa&default-theme=true

RNS Number : 2347P  Agriterra Ltd  09 December 2024

The information communicated within this announcement is deemed to constitute
inside information as stipulated under the Market Abuse Regulations (EU) No.
596/2014. Upon the publication of this announcement, this inside information
is now considered to be in the public domain.

 

Agriterra Limited / Ticker: AGTA / Index: AIM / Sector: Agriculture

 

Agriterra Limited ('Agriterra' or the 'Company')

 

Interim Results

 

Agriterra Limited, the AIM listed African agricultural company, announces its
unaudited results for the six months ended 30 September 2024.

Chair's Statement

 

I am pleased to provide an update on our performance in the first half of the
2025 financial year ('HY-2025'). These results are available on the Company's
website.

 

Operational update

 

Grain division

 

The Grain division commenced the season with a well mapped strategy targeting
to improve operational efficiency as well as securing grain as early as
possible in response to the El Nino induced drought in Southern Africa. Grain
supply was low, and prices of maize and mealie meal increased significantly.
The division had to buy grain with a high moisture content and dry to store in
silo to be able to achieve 14,700 tons meal sales volume budgeted for the
current financial year.

 

The division signed a commodity trading agreement valued at US$ 2.7 million
(MZN 200 million) in May 2024 with a local Mozambican company to purchase
maize for the year. In addition, the division secured a US$ 1.2 million
prepayment from one of their major trading customers to supply 2,500 tons of
mealie meal rateably from August 2024 to February 2025.

 

The division bought 15,635 tons of maize at an average price of US$324 per ton
during the period to 30 September 2024. The division had 10,938 tons in stock
at 30 September 2024 and milled 4,697 tons of maize producing 3,582 tons of
mealie meal at an extraction of 76%. The division sold 4,651 tons in the
period ended 30 September 2024 (HY-2024: 4,188 tons), including 1,069 tons of
imported mealie meal. The division generated US$ 3 million revenue during the
6 months ended 30 September 2024 (HY-2024: US$ 2.2 million).

 

The Grain division expects to produce 8,203 tons of mealie meal in H2-2025
from 10,938 tons of maize in silo and would require an additional 1,000 tons
to achieve the forecasted sales budget of 14,700 tons of meal for the year
ending 31 March 2025. Management is planning to import 1,000 tons of meal and
will continue purchasing maize.

 

The replacement of old equipment generated operating efficiencies helping to
reduce operating costs by US$ 0.1 million to US$ 0.5 million. The division is
reporting an unchanged EBITDA loss of US$ 0.2 million (HY-2024: EBITDA loss of
US$ 0.2 million) mainly due to lower volumes and margins in the first quarter.
Finance costs decreased to US$ 0.1 million (HY-2024: US$ 0.2 million).
Depreciation cost remained constant at US$ 0.24 million. The Grain division
incurred a loss of US$ 0.5 million for the 6-month period ended 30 September
2024 (HY-2024: Loss US$ 0.7 million).

 

Beef division

 

The Beef division commenced the year with objective of turning around the
business and enabling the division to breakeven on a monthly basis. Based on
the strategy session held in February 2024, emphasis was on improving
operational efficiencies and building on the gains achieved in prior year.

 

The premium market is supplied from the feedlot and farm, whilst the mass
market is now supplied from cattle bought in and sent directly to the
abattoir. Consequently, the number of animals at the farm decreased to 539
head at 30 September 2024 (30 September 2023; 723 head), being the estimated
demand of the premium market for the next three months. The direct slaughter
program has been a success and has enabled the division to reduce the cost of
transporting animals and other animal handling overheads. On average the
division is purchasing 300 animals per month for direct slaughter.

 

Beef division generated US$ 1.5 million revenue over the 6 months period ended
30 September 2024 (HY-2024: US$ 1.5 million). 345 tons of beef were sold
during the period (HY-2024: 430 tons of beef). A gross profit of 22.04% was
achieved (HY-2024: 20.67%). The division is looking to increase volume and
introduce further operational efficiencies to improve the Gross margin.

 

Operating expenses for the period amounted to US$ 0.4 million (HY-2024: US$
0.5 million). The Beef division incurred a loss of US$ 0.2 million for the
6-month period ended 30 September 2024 (HY-2024: Loss US$ 0.4 million).

 

Snax Division

 

Tough macroeconomic conditions, together with the El Nino induced drought, has
led to pressure on the disposable income of the local population. This has had
a significant effect on demand for the division's products. Nonetheless
despite facing stiff price competition, the division's superior quality is
helping to maintain market share.

Snax division generated revenue amounting to US$ 0.6 million (HY-2024: US$
1.03 million) over the period with a gross profit of 14.95% (HY-2024: 20.17%).
Loss for the period was US$ 0.06 million (HY-2024: Profit US$ 0.30 million).

Operating expenses for the 6 months period amounted to US$ 0.1 million
(HY-2024: US$ 0.1 million).

The Group acquired control of DECA Snax Limitada in the prior year.
Consequently, the Group is consolidating the performance of Snax division and
recognising the non-controlling interest in the Group's financial statements.
The comparatives have been restated accordingly.

 

Group Results

 

Group revenue for the half-year ended 30 September 2024 increased by 5% to US$
4.8 million (HY-2024 (restated): US$ 4.6 million) due to;

·      US$ 0.8 million increase in Grain division revenue resulting from
high selling prices even though volume remained constant.

·      Decline in Snax revenue of $ 0.5m.

Gross profit remained constant at US$ 0.7 million (HY-2024: US$ 0.7 million)
achieving a Group gross margin of 14% (HY-2024: Gross margin of 16%). Decrease
in gross margin is resulting from high cost of maize which reduced Grain
division margins to 9%. Group operating expenses decreased from US$ 1.9
million to US$ 1.5 million.

 

Finance costs increased by 55% to US$ 0.85 million (HY-2024: US$ 0.55 million)
as a result of the additional shareholder loans received in the prior year for
maize buying which were not repaid and the additional shareholder loan for the
procurement of the biscuit factory. Finance cost is mainly incurred on
shareholder loans at SOFR+6%.

 

During the period, inventories have increased by US$ 4.1 million to US$ 4.7
million as compared to 31 March 2024 (HY-2024: US$ 2.9 million). The Grain
division's inventory is expected to be used within the next 6 months.

 

Outlook for H2-2025

 

The Grain business is entering H2-2025 with 10,938 tons of grain in silo which
is not sufficient to take us to the next harvest. The division is
supplementing this by importing 1,000 tons of mealie meal from South Africa
and rolling to the extent possible, maize sold during the period. The price of
meal in the market is expected to increase in H2-2025 in line with an increase
in seasonal demand and the Grain division is well positioned to capitalize on
this and boost its revenue and margins. The Beef division's sales revenue is
expected to improve in H2-2025.

 

During H1-2025, the Biscuit division commenced trading and is expected to
contribute to increased revenue in H2-2025.

 

All divisions have been striving to be self-sustaining at low-capacity
utilisation and now are expanding into profitable operations as volumes
increase after rightsizing.

 

Grain remains the core Group business and management will seek to add value by
creating additional product lines building on the success of DECA Snax.

 

 

 CSO Havers
 Chair

 9 December 2024

 

For further information please VISIT www.agriterra-ltd.com or contact:

 

 Agriterra Limited                                                                  Strand Hanson Limited
 Caroline Havers    caroline@agriterra-ltd.com (mailto:caroline@agriterra-ltd.com)  Ritchie Balmer / James Spinney / David Asquith  Tel: +44 (0) 207 409 3494
                                                                                    Peterhouse Capital Limited
                                                                                    Duncan Vasey / Eran Zucker                      Tel: +44 (0) 207 469 0930

C
Consolidated income statement
                                                                      6 months           6 months         Year

                                                                      ended              ended            ended

                                                                      30 September       30 September     31 March

                                                                      2024               2023             2024
                                                                      Unaudited          Unaudited        Audited
                                                                                         Restated
                                                            Note      US$000             US$000           US$000
 CONTINUING OPERATIONS
 Revenue                                                    2         4,841              4,607            10,393
 Cost of sales                                                        (4,147)            (3,878)          (8,124)
 Decrease in fair value of biological assets                          -                  -                (437)
 Gross profit                                                         694                729              1,832
 Operating expenses                                                   (1,471)            (1,892)          (3,988)

 Other income                                                         73                 129              273
 Profit on disposal of property, plant and equipment                  80                 1                30
 Operating loss                                                       (624)              (1,033)          (1,853)

 Net finance costs                                          3         (853)              (550)            (1,488)
 Loss before taxation                                                 (1,477)            (1,583)          (3,341)
 Taxation                                                             -                  -                127
 Loss for the period                                        2         (1,477)            (1,583)          (3,214)

 Loss for the period attributable to owners of the Company            (1,477)            (1,583)          (3,214)

 

other comprehensive income

 Loss for the period                                                 (1,477)    (1,583)    (3,214)
 Items that will not be reclassified to profit or loss
     Revaluation of property, plant and equipment                    -          -          (141)
     Related tax                                                     -          -          45
                                                                     -          -          (96)
 Items that may be reclassified subsequently to profit or loss:
  Foreign exchange translation differences                           292        (780)      5

 Other comprehensive income/(loss) for the period                    292        (780)      (91)
 Total comprehensive loss for the period                             (1,185)    (2,363)    (3,305)

 Loss Attributable to:
 Owners of the company                                               (1,448)    (1,598)    (3,225)
 Non-controlling interest                                             (29)      15         11
                                                                     (1,477)    (1,583)    (3,214)

 Total Comprehensive loss attributable to:

 Owners of the company                                               (1,156)    (2,378)    (3,316)

 N

 Non-controlling interest                                            (29)       15         11
                                                                     (1,185)    (2,363)    (3,305)

 Earnings per Share
 Basic and diluted earnings per share (US Cents)                 4   (2.02)     (2.22)     (4.49)

Consolidated statement of financial position

 

                                                                    30 September    30 September    31 March

                                                                    2024            2023            2024

                                                                    Unaudited       Unaudited       Audited
                                                                                    Restated
                                                          Note      US$000          US$000          US$000
 Non-current assets
 Property, plant and equipment                                      24,719          24,382          24,968
 Intangible assets                                                  -               1               -
                                                                    24,719          24,383          24,968
 Current assets
 Biological assets                                                  31              292             245
 Inventories                                                        4,722           2,857           616
 Trade and other receivables                                        308             1,632           1,949
 Cash and cash equivalents                                          500             352             439
                                                                    5,561           5,133           3,249
 Total assets                                                       30,280          29,516          28,217
 Current liabilities
 Borrowings                                               5         130             1,179           130
 Trade and other payables                                           3,883           2,665           1,217
                                                                    4,013           3,844           1,347
 Net current assets                                                 1,548           1,289           1,902

 Non-current liabilities
 Borrowings                                               5         14,721          11,820          14,138
 Deferred tax liability                                             5,936           6,115           5,937
                                                                    20,657          17,935          20,075
 Total liabilities                                                  24,670          21,779          21,422

 Net assets                                                         5,610           7,737           6,795

 Share capital                                            6         56,694          63,343          56,694
 Share premium                                            6         -               -               -
 Share based payments reserve                                       67              67              67
 Revaluation reserve                                                11,588          11,935          11,714
 Translation reserve                                                (15,872)        (16,981)        (16,164)
 Accumulated losses                                                 (46,942)        (50,735)        (45,620)
 Non-controlling interest                                           75              108             104
 Equity attributable to equity holders of the parent                5,610           7,737           6,795

 

The unaudited condensed consolidated financial statements of Agriterra Limited
for the six months ended 30 September 2024 were approved by the Board of
Directors and authorised for issue on 9 December 2024.

 

Signed on behalf of the Board of Directors:

 

 

 

 CSO Havers

 Chair

 

 

Consolidated statement of changes in equity

 

 

                                                                                              Share         Share premium                             Share based payment reserve      Translation reserve      Revaluation reserve      Accumulated      Non-Controlling Interest                Total

losses

                                                                                              capital                                                                                                                                                                                             Equity

                                               Note                                           US$000        US$000                                    US$000                           US$000                   US$000                   US$000           US$000                                  US$000

 Balance at 1 April 2023                                                                      3,993         151,419                                   67                               (16,169)                 12,061                   (141,364)        -                                       10,007
 Loss for the period                                                                          -             -                                         -                                -                        -                        (1,598)          15                                      (1,583)
 Other comprehensive income:
 Exchange translation loss on foreign operations restated                                     -             -                                         -                                (780)                    -                        -                -                                       (780)
 Total comprehensive loss for the period                                                      -             -                                         -                                (780)                    -                        (1,598)                                                  (2,363)

                                                                                                                                                                                                                                                          15
 Transactions with owners
 Acquisition of subsidiary with NCI                                                           -             -                                         -                                -                        -                        -                                                        93

                                                                                                                                                                                                                                                          93
 Reclassification                                                                             59,350        (151,419)                                 -                                -                        -                        92,069           -                                       -
 Revaluation surplus realised                                                                 -                                                       -                                -                        (126)                    126                                                      -

                                                                                                            -                                                                                                                                             -
 Total transaction with owners for the period                                                 59,350        (151,419)                                 -                                -                        (126)                      92,195                                                 93

                                                                                                                                                                                                                                                          93
 Balance at 30 September 2023                                                                  63,343       -                                         67                               (16,949)                 11,935                   (50,767)         108                                     7,737
 Loss for the period                                                                          -             -                                         -                                -                        -                        (1,627)          (4)                                     (1,631)
 Other comprehensive income:                                                                  -             -                                         -                                -                        (96)                     -                -                                       (96)

 Revaluation of property, plant and equipment (net)
 Exchange translation gain on foreign operations                                              -             -                                         -                                785                      -                        -                -                                       785
 Total comprehensive loss for the period                                                      -             -                                         -                                785                      (96)                     (1,627)          (4)                                     (942)
 Transactions with owners
 Reclassification                                                                             (6,649)       -                                         -                                -                        -                        6,649            -                                       -
 Revaluation surplus realised                                                                 -             -                                         -                                -                        (125)                    125                                                      -

                                                                                                                                                                                                                                                          -
 Total transactions with owners for the period                                                (6,649)       -                                         -                                -                        (125)                    6,774                                                    -

                                                                                                                                                                                                                                                          -
 Balance at 31 March 2024                                                                     56,694        -                                         67                               (16,164)                 11,714                   (45,620)                                                 6,795

                                                                                                                                                                                                                                                          104
 Loss for the period                                                                          -             -                                         -                                -                        -                        (1,448)          (29)                                       (1,477)
 Other comprehensive income:                                                                  -             -                                         -                                292                      -                        -                -                                       292

 Exchange translation gain on foreign operations
 Total comprehensive loss for the period                                                      -             -                                         -                                292                      -                        (1,448)                                                  (1,185)

                                                                                                                                                                                                                                                          (29)
 Transactions with owners
 Revaluation surplus realised                                                                 -             -                                         -                                -                        (126)                    126              -                                       -
 Total transactions with owners for the period                                                -                               -                       -                                -                        (126)                    126                                                      -

                                                                                                                                                                                                                                                          -
 Balance at 30 September 2024                                                                 56,694        -                                         67                               (15,872)                 11,588                   (46,942)         75                                      5,610

 

 

 

 

 

 

Consolidated cash flow statement

 

                                                                          Note      6 months ended    6 months ended    Year

                                                                                    30 September      30 September       ended

                                                                                    2024              2023              31 March

                                                                                    Unaudited         Unaudited         2024

                                                                                                                        Audited
                                                                                                      Restated
                                                                                    US$000            US$000            US$000

 Loss before tax for the period                                                     (1,477)           (1,583)           (3,341)
 Adjustments for:
 Amortisation and depreciation                                            2         396               434               871
 Profit on disposal of property, plant and equipment                                (80)              -                 (30)
 Impairment of goodwill on acquisition                                              -                 -                 12
 Foreign exchange loss/(gain)                                                       279               (622)             (48)
 Changes in value of biological assets                                              -                                   437

                                                                                                      -
 Net Finance costs                                                                  853               550               1,488
 Operating cash flows before movements in working capital                           (29)              (1,221)           (611)
 Decrease/(increase) in biological assets                                           214               204               (186)
 (Increase)/decrease in inventories                                                 (4,106)           (2,307)           389
 Decrease/(increase) in trade and other receivables                                 1,641             (582)             (956)
 Increase/(decrease) in trade and other payables                                    2,666             2,007             (155)
 Net Cash generated from/ (used in) operating activities                            386               (1,899)           (1,519)

 Cash flows from investing activities
 Proceeds from disposal of property, plant and equipment net of expenses            80                1                 30
 incurred
 Acquisition of property, plant and equipment                                       (135)             (511)             (1,271)
 Acquisition of subsidiary net of cash acquired                                     -                 -                 48
 Net cash used in investing activities                                              (55)              (510)             (1,193)

 Cash flow from financing activities
 Finance costs                                                            3         (180)             (167)                                                (485)
 Net repayment of loans                                                   5         (90)              (146)             (940)
 Net repayment of leases                                                  5         -                 -                 (198)
 Net drawdown of shareholder loans                                                  -                 2,900             4,600

 Net cash (used in)/ generated from financing activities                            (270)             2,587              2,977

 Net increase in cash and cash equivalents                                          61                178               265
 Effect of exchange rates on cash and cash equivalents                              -                 -                 -
 Cash and cash equivalents at beginning of period                                   439               174               174
 Cash and cash equivalents at end of period                                         500               352               439

 

 

 

 

 

 

 

 

 

General information

 

Agriterra Limited ('Agriterra' or the 'Company') and its subsidiaries
(together the 'Group') is focussed on the agricultural sector in Africa.
Agriterra is a non-cellular company limited by shares incorporated and
domiciled in Guernsey, Channel Islands. The address of its registered office
is St. Peter's House, Rue des Brehauts, St. Pierre du Bois, Guernsey GY7 9RT.

 

The Company's Ordinary Shares are quoted on the AIM Market of the London Stock
Exchange ('AIM').

 

The unaudited condensed consolidated financial statements have been prepared
in United States Dollars ('US$' or 'US$') as this is the currency of the
primary economic environment in which the Group operates.

 

1.            Basis of preparation

 

The condensed consolidated financial statements of the Group for the 6 months
ended 30 September 2024 (the 'H1-2025 financial statements'), which are
unaudited and have not been reviewed by the Company's Auditor, have been
prepared in accordance with the International Financial Reporting Standards
('IFRS'). The accounting policies adopted by the Group are set out in the
annual report for the year ended 31 March 2024 (available at
www.agriterra-ltd.com). The Group does not anticipate any significant change
in these accounting policies for the year ended 31 March 2025.

 

This interim report has been prepared to comply with the requirements of the
AIM Rules of the London Stock Exchange (the 'AIM Rules'). In preparing this
report, the Group has adopted the guidance in the AIM Rules for interim
accounts which do not require that the interim condensed consolidated
financial statements are prepared in accordance with IAS 34, 'Interim
financial reporting'. Whilst the financial figures included in this report
have been computed in accordance with IFRSs applicable to interim periods,
this report does not contain sufficient information to constitute an interim
financial report as that term is defined in IFRSs.

 

The financial information contained in this report also does not constitute
statutory accounts under the Companies (Guernsey) Law 2008, as amended. The
financial information for the year ended 31 March 2024 is based on the
statutory accounts for the year then ended. The Auditors reported on those
accounts. Their report was unqualified and referred to going concern as a key
audit matter. The Auditors drew attention to note 3 to the 31 March 2024
financial statements concerning the Group's ability to continue as a going
concern which shows that the Group needs to achieve its operating targets and
is reliant on the continued support from the largest shareholder in order to
continue as a going concern.

 

The H1-2025 financial statements have been prepared in accordance with the
IFRS principles applicable to a going concern, which contemplate the
realisation of assets and liquidation of liabilities during the normal course
of operations. Having carried out a going concern review in preparing the
H1-2025 financial statements, the Directors have concluded that there is a
reasonable basis to adopt the going concern principle.

 

 

2.            Segment information

 

The Board considers that the Group's operating activities during the period
comprised the segments of Grain, Beef and Snax, undertaken in Mozambique. In
addition, the Group has certain other unallocated expenditure, assets and
liabilities.

The following is an analysis of the Group's revenue and results by operating
segment:

 

 6 months ended 30 September 2024 - Unaudited  Grain                                Beef        Snax        Unallo-cated      Elimina-tions        Total

                                               US$000                               US$000      US$000      US$000            US$000               US$000
 Revenue
 External sales ((2))                          2,786                                1,483       572         -                 -                    4,841
 Inter-segment sales ((1))                     197                                  -           -           -                 (197)                -
                                               2,983                                1,483       572         -                 (197)                4,841

 Segment results
 - Operating loss                              (468)                                (80)        (58)        (91)              -                    (697)
 - Interest income                                            77                    -           -           -                     (77)             -
 - Interest expense                            (180)                                (77)        -           (673)                    77            (853)
 - Other gains and losses                      73                                   -           -           -                 -                    73
 Loss before tax                               (498)                                (157)       (58)        (764)             -                    (1,477)

 Income tax                                    -                                    -           -           -                 -                    -
 Loss for the period                           (498)                                (157)       (58)        (764)             -                    (1,477)

 

 

 

 6 months ended 30 September 2023 - Unaudited  Grain     Beef      Snax      Unallo-cated    Elimina-tions    Total

 Restated
                                               US$000    US$000    US$000    US$000          US$000           US$000
 Revenue
 External sales ((2))                          2,066     1,509     1,032     -               -                4,607
 Inter-segment sales ((1))                     117       -                   -               (117)            -
                                               2,183     1,509     1,032     -               (117)            4,607

 Segment results
 - Operating loss                              (620)     (316)     30        (256)           -                (1,162)
 - Interest expense                            (184)     (70)      -         (296)           -                (550)
 - Other gains and losses                      128       1         -         -               -                129
 (Loss)/Profit before tax                      (676)     (385)     30        (552)           -                (1,583)

 Income tax                                    -         -         -         -               -                -
 (Loss)/Profit for the period                  (676)     (385)     30        (552)           -                (1,583)

 

The results for the half year to 30 September 2023 have been restated to
reflect that the Company took control of DECA Snax with effect from 1 April
2023 and accordingly the financial statements of DECA Snax have been
consolidated into the Group accounts for the period.

 

 Year ended 31 March 2024 - Audited               Grain       Beef         Snax        Unallo-cated      Elimina-tions      Total

                                                  US$000      US$000       US$000      US$000            US$000             US$000
 Revenue
 External sales ((2))                             5,354       2,967        2,072       -                 -                  10,393
 Inter-segment sales ((1))                        816         -            -           -                 (816)              -
                                                  6,170       2,967        2,072       -                 (816)              10,393
 Segment results
 - Operating loss                                 (728)       (963)        5           (440)             -                  (2,126)
 - Interest expense                               (292)       (193)        -           (1,003)           -                  (1,488)
 - Other gains and losses                         237         4            18          14                -                  273
 - Share of profit in equity-accounted investees  -           -            -           -                 -                  -
 (Loss)/Profit before tax                         (783)       (1,152)      23          (1,429)           -                  (3,341)
 Income tax                                       115         12           -           -                 -                  127
 (Loss)/Profit after tax                          (668)       (1,140)      23          (1,429)           -                  (3,214)

 

(1)        Inter-segment sales are charged at prevailing market prices

(2)        Revenue represents sales to external customers and is
recorded in the country of domicile of the Company making the sales. Sales
from the Grain, Beef and Snax divisions are principally for supply to the
Mozambique market.

 

The segment items included within continuing operations in the consolidated
income statement for the periods are as follows:

 

                                               Grain       Beef        Snax         Unallo-cated      Elimina-tions      Total

                                               US$000      US$000      US$000       US$000            US$000             US$000
 6 months ended 30 September 2024 - Unaudited
 Depreciation and amortisation                 235         121         40           -                 -                  396

 

 6 months ended 30 September 2023 - Unaudited
 Depreciation and amortisation                 236    160    38    -    -    434

 Year ended 31 March 2024 - Audited
 Depreciation and amortisation                 470    326    75    -    -    871

 

 

 

3.      NET FINANCE COSTS

                                              6 months ended      6 months ended    Year

                                              30 September        30 September       ended

                                              2024                2023              31 March

                                              Unaudited           Unaudited         2024

                                                                                    Audited
                                              US$000              US$000            US$000
 Interest expense:
 Bank loans, overdrafts and finance leases    180                 166               485
 Shareholder loans                            673                 384               1,003
 Interest income:
 Bank deposits                                -                   -                 -
                                              853                 550               1,488

4.      LOSS per share

 

 The calculation of the basic and diluted loss per share is based on the
 following data:
                                                                                  6 months          6 months        Year

                                                                                   ended             ended           ended
                                                                                  30 September      30 September    31 March
                                                                                  2024              2023            2024
                                                                                  Unaudited         Unaudited       Audited
                                                                                  US$000            US$000          US$000

 Loss for the period/year for the purposes of basic and diluted earnings per      (1,448)           (1,598)         (3,225)
 share attributable to equity holders of the Company

 Weighted average number of Ordinary Shares for the purposes of basic and                                           71,829,007
 diluted loss per share

                                                                                  71,829,007        71,829,007

 Basic and diluted loss per share - US cents                                      (2.02)            (2.22)          (4.49)

 

The Company has issued options over ordinary shares which could potentially
dilute basic loss per share in the future. There is no difference between
basic loss per share and diluted loss per share as the potential ordinary
shares are anti-dilutive.

 

 

5.      Borrowings

                    30 September 2024      30 September 2023    31 March

                                                                2024
                    Unaudited              Unaudited            Audited
                    US$000                 US$000               US$000

 Non-current
 Shareholder loans  14,310                 11,317               13,637
 Bank loans         411                    503                  501
 Leases             -                      -                    -
                    14,721                 11,820               14,138
 Current
 Overdrafts         -                      -                    -
 Bank loans         130                    1,058                130
 Leases             -                      121                  -
                    130                    1,179                130

                    14,851                 12,999               14,268

 

Group

 

During the period, Agriterra Limited secured shareholder loans amounting to
$Nil (2024: US$4.6 million) from Chepstow Investments Limited at an interest
rate of SOFR+6%. A portion of these loans was used to repay commercial
borrowings in Mozambique which were charged interest above 18% per annum. The
shareholder loans are made up of:

 

·      US$ 6.1m convertible loan facility with a 3-year tenure maturing
in July 2025.

·      US$ 1.8m convertible loan facility with a 12-month tenure
maturing in July 2023, which was renewed for the same period in July 2024 and
renewed again for the same period after year end to July 2025.

·      US$ 2.0m convertible loan facility with a 12-month tenure
maturing in August 2024 and was renewed for the same period after year end to
August 2025.

·      US$ 1.7m loan facility with a 12-month tenure maturing in
November 2024, with the option to renew for a further 12-month period at that
date.

·      US$ 0.9m loan facility maturing on 31 March 2026, with the option
to extend for a further 12-month period at that date.

 

In the event of default or at the option of the lender, the outstanding
principal and interest may be converted into new ordinary shares at the
prevailing market price of the Company`s shares at such time. The market price
is determined by the 10-day VWAP. The difference between the 10-day VWAP and
the closing market price is a derivative liability the value of which is not
considered to be material. Accordingly, the principal of the convertible loans
has been recorded in full as a financial liability.

 

All shareholder loans have been classified as non-current as they are
subordinated to bank loans and would not be repaid before the bank loans have
been repaid. In addition, the shareholder loans can be renewed for further
periods based on a request from the Company at the time of maturity.

 

Grain division

 

At 30 September 2024, the Grain division has one outstanding commercial bank
loan amounting to US$ 0.54 million secured by land and buildings valued at US$
6.1 million.

 

Beef division

 

Beef division does not have any finance facilities as at 30 September 2024.

 

 

Reconciliation to cash flow statement

                                At 31         Cash flow      Interest accrued      Foreign Exchange      At 30 September 2024

                                 March

                                2024
                                US$000        US$000         US$000                US$000                US$000
 Non-current shareholder loans  13,637        -              673                   -                     14,310
 Non-current bank loans         501           (90)           -                     -                     411
 Current bank loans             130           -              -                     -                     130

                                14,268        (90)           673                   -                     14,851

 

6.      Share capital

                                                              Authorised       Allotted and fully paid
                                                              Number           Number                       US$000
 Ordinary Shares
 At 30 September 2023                                         74,038,389       71,829,007                   63,105
 Reclassification                                             -                -                            (6,649)
 31 March 2024 and 30 September 2024                          74,038,389       71,829,007                   56,456
 Deferred shares of 0.1p each
 At 30 September 2023, 31 March 2024 and 30 September 2024    155,000,000      155,000,000                  238
 Total Share Capital                                          229,038,389      226,829,007                  56,694

 

The Company has one class of ordinary share which carries no right to fixed
income.

 

The deferred shares carry no right to any dividend; no right to receive
notice, attend, speak or vote at any general meeting of the Company; and on a
return of capital on liquidation or otherwise, the holders of the deferred
shares are entitled to receive the nominal amount paid up after the repayment
of £1,000,000 per ordinary share. The deferred shares may be converted into
ordinary shares by resolution of the Board.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR UPGAGPUPCGAR

Recent news on PACSCo

See all news